Biogen’s headcount grows by 23%

Biogen grew its total number of employees by 1,700, or 23%, despite the continued uncertainty over whether its make-or-break drug to treat Alzheimer’s disease will ultimately get approval. Read More

Read More

Baker sends back climate bill with amendments

Gov. Charlie Baker still is not on board with the climate policy bill overwhelmingly passed by the Legislature twice in about a month, but this time he has sent it back with proposed amendments he says would make the legislation more palatable. Read More

Read More

Consultant to Cambridge gene therapy firm charged with insider trading

A biotech consultant who advised Dimension Therapeutics on a potential acquisition in 2017 has been charged with insider trading. The 58-year-old man is facing parallel criminal charges from the U.S. Attorney’s Office for the District of Massachusetts and civil charges from the U.S. Securities and Exchange Commission. If convicted, he faces up to 25 years…

Read More